Previous researches have shown that insulin can prompt the proliferation of pancreatic cancer cells, and that insulin resistance accelerates the progression of pancreatic ductal carcinoma in animal studies [81,82]. This evidence concerns the gene INS and pancreatic ductal adenocarcinoma.